|
|
|
|
|
|
|
26.02.26 - 12:51
|
Teleflex Announces Quarterly Dividend (Business Wire)
|
|
|
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 31, 2026, to shareholders of record at the close of business on March 6, 2026. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel??...
|
|
|
|
|
26.02.26 - 12:33
|
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook (Business Wire)
|
|
|
Announces Restructuring to Right-Size and Reduce Cost Structure Related to Announced Strategic DivestituresWAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the year ended December 31, 2025.
Full year 2025 continuing operations financial summary1
GAAP revenue from continuing operations of $1,992.7 million, up 17.2% compared to the prior year period1
Adjusted revenue from continuing operations of $1,983.7 million, up 16.3% compared to the prior year period, and up 15.4% on an adjusted constant currency basis2
GAAP diluted EPS from continuing operations of $1.31, compared to $1.21 in the prior year period
Adjusted diluted EPS from continuing operations of $6.98, compared to $6.42 in the prior year period
2026 continuing operations guidance summary1
GAAP revenue growth guidance range of 14.40% to 15.40%
Pro forma adjusted constant currency revenue growth guidance range of 4.50% to 5.50%3
GAAP EPS from continuing operations guidance range ...
|
|
|
|
|
|
|
24.02.26 - 13:06
|
Diality Appoints Peter Donato as Chief Financial Officer (Business Wire)
|
|
|
Life sciences veteran brings private and public sector expertise to company in midst of growth trajectoryIRVINE, Calif.--(BUSINESS WIRE)--#CFO--Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027.
Donato joins Diality with nearly 35 years of financial leadership experience, including over 23 years of both public and private company roles primarily in the life science industry. Prior to joining Diality, he served as CFO of heart failure device company Impulse Dynamics, and before that, chief financial and administrative officer of companion pet health company Zomedica (NYSE:ZOM). Donato also held the role of executive vice president and CFO of Standard Bariatrics, sold to Teleflex (NYSE:T...
|
|
|
|
|
17.02.26 - 12:33
|
Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information (Business Wire)
|
|
|
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, 2026.
To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.com.
An audio replay of the call will be available beginning at 11:00 am Eastern Time on February 26, 2026, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in t...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
